Sentence examples for measures analysis of the from inspiring English sources

Current research activities in the field of patient-reported outcomes include the development of new (disease-specific) instruments, head-to-head comparisons of psychometric properties of measures, analysis of the context-dependence of results, and application of patient-reported outcomes in clinical practice.

The repeated measures analysis of the six dietary behaviors estimated a single association of substance use on the overall diet quality.

During the five predation assays it was occasionally necessary to select new plants, preventing a repeated measures analysis of the predation data; however, newly selected plants were matched as described.

The repeated measures analysis of the data from a TES in rheumatology should include the area under the curve of absolute disease activity (ie, not dichotomous response/change) preferentially expressed as a score (eg, DAS, SDAI, etc).

Note: * p <.05; ** p <.01: *** p <.001 ns not significant; scores for both groups were compared with one-way analyses of variance (ANOVAs) for the primary outcome measure and for all secondary outcome measures Analysis of the child-completed measures indicated that CBT focusing on cognition was associated with significant pre-treatment-to-post-treatment improvement.

Repeated measures analysis of variance, the Friedman test, the Mann-Whitney U test, and the Pearson correlation were performed for data analysis.

The group recommended that the federal Natural Resource Damage Assessment and Restoration program consider "ecosystem services" when it calculates the impact of the BP spill, a difficult-to-measure analysis of the services performed by an ecosystem.

A repeated-measures analysis of the covariance (RM ANCOVA) model was used to evaluate the primary efficacy variable within the TS and PS.

Further support was provided by Student's t-test of the linear and percentage changes and by a repeated-measures analysis of the linear trend over time.

Sample sizes available for repeated-measures analysis of the HRQL follow-up at 12, 36, and 48 months were N = 921, N = 549, and N = 208 for intensive treatment and N = 937, N = 583, and N = 208 for standard therapy.

Preliminary repeated-measures analysis of the IgG3 data indicated no significant difference in the responses over time (F = 0.123, p = 0.884); however not all children contributed blood samples at all surveys.